https://www.europeanpharmaceuticalreview.com/news/185371/mhra-authorises-new-covid-19-vaccine/
The new COVID-19 vaccine authorised by the MHRA contains an adjuvant and is indicated for patients over 16 years old.
Create an account or login to join the discussion